Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
PharmaCorp Rx has acquired PharmaChoice Canada pharmacies, a pharmacy business in Canada, for $24.2 million. PharmaChoice Canada operates pharmacist-led community pharmacy locations, and PharmaCorp Rx acquisitions expand its healthcare M&A footprint in Eastern Canada while preserving local managing pharmacists. The pharmacy acquisition adds eight bannered stores, increasing PharmaCorp Rx’s presence from six to fourteen locations and strengthening market density in major urban areas plus rural communities. The strategic acquisition is structured as an add on acquisition by a strategic buyer, with PharmaCorp Rx Rx planning integration of the acquired locations and funding the purchase from existing cash resources; additional letters of intent cover four more potential pharmacy acquisition targets.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026